TMDX — TransMedics Cashflow Statement
0.000.00%
Last trade - 00:00
- $4.28bn
- $4.44bn
- $241.62m
2019 December 28th | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 52 W | 53 W | 52 W | 52 W | 52 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -33.5 | -28.7 | -44.2 | -36.2 | -25 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 1.67 | 2.49 | 10.5 | 13.7 | 49.8 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1.63 | -5.59 | 3 | -26.8 | -44.3 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -32.3 | -30.3 | -28.9 | -45.8 | -13 |
Capital Expenditures | -0.165 | -0.455 | -3.52 | -11.9 | -152 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -60.3 | -41.1 | 32.8 | 66.4 | -42.1 |
Acquisition of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -60.5 | -41.6 | 29.3 | 54.5 | -194 |
Financing Cash Flow Items | 92.5 | -0.705 | 0 | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 92.7 | 75.5 | 1.39 | 168 | 400 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.149 | 4.49 | 0.999 | 176 | 194 |